Napredna pretraga

Pregled bibliografske jedinice broj: 664813

Addition of rituximab to high-dose methotrexate-based chemotherapy improves survival of adults with Burkitt lymphoma / leukemia


Dujmović, Dino; Aurer, Igor; Radman, Ivo; Serventi-Seiwerth, Ranka; Dotlić, Snježana; Štern-Padovan, Ranka; Dubravčić, Klara; Šantek, Fedor; Labar, Boris
Addition of rituximab to high-dose methotrexate-based chemotherapy improves survival of adults with Burkitt lymphoma / leukemia // Acta haematologica, 127 (2012), 2; 115-117 doi:10.1159/000334705 (međunarodna recenzija, pismo, znanstveni)


Naslov
Addition of rituximab to high-dose methotrexate-based chemotherapy improves survival of adults with Burkitt lymphoma / leukemia

Autori
Dujmović, Dino ; Aurer, Igor ; Radman, Ivo ; Serventi-Seiwerth, Ranka ; Dotlić, Snježana ; Štern-Padovan, Ranka ; Dubravčić, Klara ; Šantek, Fedor ; Labar, Boris

Izvornik
Acta haematologica (7891-352X) 127 (2012), 2; 115-117

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo, znanstveni

Ključne riječi
Burkitt lymphoma; rituximab; methotrexate; combined antineoplastic chemotherapy protocols

Sažetak
The paper describes our results in treatment of Burkitt lymphoma / leukemia with rituximab and high-dose methotrexate based chemotherapy.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekt / tema
108-1081872-1908 - Dijagnostika i liječenje limfoma (Igor Aurer, )

Ustanove
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • SCI-EXP, SSCI i/ili A&HCI


Citati